Cencora (COR)

Cencora sources, warehouses, and distributes branded, generic, and specialty medicines to a broad customer base that includes retail pharmacy chains, independent pharmacies, mail-order providers, hospitals, health systems, clinics, and other healthcare professionals. Its scale is important in an industry where reliable logistics, regulatory compliance, inventory management, and timely delivery are essential to patient care. The company is especially exposed to specialty pharmaceuticals, a high-value segment that includes complex therapies often used to treat cancer, autoimmune conditions, and rare diseases.

Beyond wholesale distribution, Cencora provides services that help drug and medical device manufacturers commercialise products and manage access to therapy. These activities can include market access support, patient services, reimbursement assistance, and logistics for sensitive or temperature-controlled products. Through World Courier, it has a recognised presence in specialty logistics, including global clinical trial and biopharma supply chain services. Its MWI Animal Health business extends the company’s distribution model into veterinary and animal health markets.

Cencora expanded its international footprint with the acquisition of Alliance Healthcare, strengthening its position in European pharmaceutical wholesale and related services. The company’s distinctive role lies in its scale, network density, and position as a key infrastructure provider within pharmaceutical supply chains.